Trial Profile
A Double-Masked, Parallel-Group, Randomized, Single-Dose Bioequivalence Study of Tobradex AF Suspension and TOBRADEX Ophthalmic Suspension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2014
Price :
$35
*
At a glance
- Drugs Tobramycin/dexamethasone (Primary)
- Indications Cataracts
- Focus Therapeutic Use
- Sponsors Alcon
- 25 Nov 2014 New trial record